The June 2 issue of JNCI highlights a study and editorial on a new broad-spectrum vaccine for cervical cancer. It also includes a study on the protein known as phosphatase 2A or CIP2A in gastric cancer; the lifelong cancer incidence in patients treated for childhood cancer; the variability in how accurately different facilities interpret diagnostic mammograms; and the peptide RasGAP's effect on colon cancer in mice.
